A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans a ...

The U.S. Food and Drug Administration (FDA) has approved pharmaceutical company Novo Nordisk’s (NVO) Ozempic medication to ...

The number of prescriptions for obesity medications rose an average of 5.3% annually from 2017 to 2024 and corresponded with ...

Hims & Hers may leverage FDA compounding exemptions to further extend its compounded GLP-1 offerings. Learn why HIMS stock is ...

Telehealth company Hims & Hers is playing offense in a new commercial slated to air during the Super Bowl next month. | Telehealth company Hims & Hers is playing offense in a new commercial slated to ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing kidney failure risk, disease progression, and death due to ...

The Office of Personnel Management's 2026 Federal Employees Health Benefits program roadmap focuses on cutting red tape for ...

MyFitnessPal, the No. 1 global nutrition and food tracking app, is shining a light on unusual, weird, and potentially harmful fad diets with the FadLab, an interactive experience designed to promote ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

Clinics in Columbus, Cleveland, Dayton, and Cincinnati have lost their licenses to distribute dangerous drugs after the Ohio ...

Singer Avery has been diagnosed with a condition that's thought to affect over 10 million Americans after she began using ...

The FDA's move may change how doctors treat chronic kidney disease, which, according to Ozempic maker Novo Nordisk, affects around 37 million Americans and is one of the leading causes of death in the ...